“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057. Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018 Year: 2018
“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444. Source: Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017 Year: 2018
“Exercise pulmonary haemodynamics: a test in search of purpose.” J. Gerry Coghlan and Harm Jan Bogaard. Eur Respir J 2016; 47: 1315–1317. Source: Eur Respir J 2016; 48: 285 Year: 2016
“Number needed to treat: enigmatic results for exacerbations in COPD.” Samy Suissa. Eur Respir J 2015; 45: 875–878. Source: Eur Respir J, 51 (6) 1452165; 10.1183/13993003.52165-2014 Year: 2018
“Do bacteria have a role in asthma development?” J. Armann and E. von Mutius. Eur Respir J 2010; 36: 469–471. Source: Eur Respir J, 54 (1) 1050414; 10.1183/13993003.50414-2010 Year: 2019
“Health consequences associated with frequent wheezing in adolescents without asthma diagnosis.” K. Yeatts, K. Johnston Davis, D. Peden and C. Shy. Eur Respir J 2003; 22: 781–786. Source: Eur Respir J 2015; 46: 1532 Year: 2015
“Alveolar macrophages carbon load: a marker of exposure?” Chinedu Nwokoro, Rossa Brugha and Jonathan Grigg. Eur Respir J 2013; 41: 763. Source: Eur Respir J 2013; 42: 295 Year: 2013
“The therapy of idiopathic pulmonary fibrosis: what is next?” Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, et al . Eur Respir Rev 2019; 28: 190021. Source: Eur Respir Rev, 28 (153) 195021; 10.1183/16000617.5021-2019 Year: 2019
“Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.” Bridget F. Collins and Ganesh Raghu. Eur Respir Rev 2019; 28: 190022. Source: Eur Respir Rev, 28 (154) 195022; 10.1183/16000617.5022-2019 Year: 2019
“Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.” Stephen Y. Chan and Lewis J. Rubin. Eur Respir Rev 2017; 26: 170094. Source: Eur Respir Rev, 27 (147) 175094; 10.1183/16000617.5094-2017 Year: 2018
“Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options.” Winfried Randerath, Oana Deleanu, Sophia Schiza and Jean-Louis Pepin. Eur Respir Rev 2019; 28: 190084. Source: Eur Respir Rev, 28 (154) 195084; 10.1183/16000617.5084-2019 Year: 2019
“Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.” Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. Eur Respir Rev 2017; 26: 170050. Source: Eur Respir Rev, 27 (148) 175050; 10.1183/16000617.5050-2017 Year: 2018
“Reproducibility of 6-minute walking test in patients with COPD”. N.A. Hernandes, E.F.M. Wouters, K. Meijer, J. Annegarn, F. Pitta and M.A. Spruit. Eur Respir J 2011; 38: 261–267. Source: Eur Respir J 2012; 40: 1583 Year: 2012
“Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.” A.U. Wells, J. Behr, U. Costabel, V. Cottin and V. Poletti. Eur Respir J 2012; 39: 805–806. Source: Eur Respir J 2012; 39: 1552 Year: 2012
“Asthma inhaler adherence determinants in adults: systematic review of observational data.” Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994–1018. Source: Eur Respir J 2016; 47:1892 Year: 2016
“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020
“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051. Source: Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019 Year: 2020
“Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. Source: Eur Respir Rev 2015; 24: 545 Year: 2015
“Umeclidinium in patients with COPD: a randomised, placebo-controlled study.” Roopa Trivedi, Nathalie Richard, Rashmi Mehta and Alison Church. Eur Respir J 2014; 43: 72–81. Source: Eur Respir J 2014; 44: 555 Year: 2014
“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784. Source: Eur Respir J 2016; 48: 593 Year: 2016